Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Tenet Healthcare Corp (NYSE: THC) saw many of its key financial metrics improve in Q3 FY21. Adjusted EPS came in at $1.99, more than double than $0.64 a year ago and ahead of the Wall Street estimate of $1.02.

Tenet Achieves Quarterly Operating Income Of $1B, Raises FY21 Outlook

Tenet (THC) delivered earnings and revenue surprises of 82.57% and 1.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Q3 Earnings and Revenues Beat Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2021 (Q3'21). Tenet's results for Q3'21 versus the quarter ended September 30, 2020 (Q3'20) and for the nine months ended September 30, 2021 (YTD Q3'21) versus the nine months ended September 30, 2020 (YTD Q3'20) follow: ($ in millions, except per share results) Q3'21 Q3'20 YTD Q3'21 YTD Q3'20 Net income available (loss attributable) to Tenet common sharehold

Tenet Reports Third Quarter 2021 Results; Raises 2021 Financial Guidance

Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Tenet Healthcare (THC) Ahead of Earnings?

Tenet Healthcare (NYSE:THC) is set to give its latest quarterly earnings report on Wednesday, 2021-10-20. Here's what investors need to know before the announcement.

Earnings Preview: Tenet Healthcare

Tenet (THC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down 14.9% in 4 Weeks, Here's Why Tenet (THC) Looks Ripe for a Turnaround

DALLAS--(BUSINESS WIRE)--United Surgical Partners International (USPI), a subsidiary of Tenet Healthcare Corporation (NYSE: THC), today announced that it has entered into a definitive agreement with Compass Surgical Partners (Compass) to purchase its ownership and management interests in nine ambulatory surgery centers (ASCs). Upon completion of the transaction, USPI will manage and jointly own the centers through partnerships with approximately 125 physicians, as well as with local health syst

USPI to Acquire Interests in Nine Ambulatory Surgery Centers from Compass Surgical Partners

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its third quarter ending September 30, 2021 after the market closes on Wednesday, October 20, 2021. The company will host a related conference call the following morning, Thursday, October 21, 2021, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors.

Tenet to Report its Third Quarter 2021 Results on October 20

Community Health Systems

HCA Healthcare

High patient volumes, mergers and buyouts and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH outperform the S&P Index.

3 Hospital Stocks That Outperformed the S&P Index Year to Date

Cigna

Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.

Tenet Healthcare (THC) Expands Its Relationship With Cigna

DALLAS & BLOOMFIELD, Conn.--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) and Cigna Corporation (NYSE: CI) today announced that they have extended and expanded their network access through the signing of a new multi-year contract. The agreement will provide Cigna customers with continued in-network access through 2025 to Tenet's hospitals, physician clinics and outpatient centers, including the ambulatory facilities operated by United Surgical Partners International that are consoli

Tenet and Cigna Extend and Expand Network Access

Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it achieve its rally.

Tenet Healthcare (THC) Hits 52-Week High: More Upside Left? (Revised)

Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it aid its upsurge.

Tenet Healthcare (THC) Hits 52 Week High: More Upside Left?

Acadia Healthcare

Universal Health Services

Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.

4 Hospital Stocks Likely to Perform Well in 2H21

The shares of Tenet Healthcare Corp (NYSE:THC)  are up 0.7% to trade at $73.13 this afternoon.

Tenet Healthcare Stock Has More Room to Run

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Why Is Tenet (THC) Down 0.8% Since Last Earnings Report?

To boost financial flexibility, Tenet Healthcare (THC) announces partial redemption of senior secured notes to procure funds for paying down its future annual cash interest payments.

Tenet Healthcare (THC) Announces Partial Redemption of Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of $1.100 billion of the $1.870 billion aggregate principal amount of its outstanding 4.625% senior secured first lien notes due July 15, 2024 (the “Notes”). As a result, Tenet expects to lower its future annual cash interest payments by approximately $50 million. This retirement of debt will be funded with approximately $1.100 billion of proceeds from the recent sale of the Company's five hospital

Tenet Calls for Partial Redemption of 4.625% Senior Secured First Lien Notes due 2024

Tenet Healthcare Corp. THC, -1.43% said late Monday that Ron Rittenmeyer, who has served as chief executive and executive chairman for nearly four years, will step down as CEO, to be replaced by Saum Sutaria. Rittenmeyer will continue as executive chairman of the company and the board through 2022, Tenet said.

Tenet names Saum Sutaria its next CEO, Rittenmeyer to remain chairman

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the next step in its long-term leadership succession plan. Ron Rittenmeyer, who has served as CEO and Executive Chairman for nearly four years, will continue as Executive Chairman of the Company and the Board through 2022. Saum Sutaria, M.D., President and Chief Operating Officer of Tenet, will become Chief Executive Officer, effective September 1, 2021. He will continue to report to Rittenmeyer. “When I joined Te

Tenet Announces Leadership Transition

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of its five hospitals and related operations in the Miami-Dade and Southern Broward counties. The transaction includes Coral Gables Hospital, Florida Medical Center, Hialeah Hospital, North Shore Medical Center and Palmetto General Hospital, as well as associated physician practices and other entities. Tenet's ambulatory facilities operated by United Surgical Partners International i

Tenet Completes Sale of Five Hospitals in the Miami-Dade/Southern Broward Area

For-profit hospital companies are seeing earnings spring back to life this year after getting hit hard by the COVID-19 pandemic.

3 Rising Hospital Stocks to Buy Right Now

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the results of its 2021 Healthy Over Hungry® Cereal Drive. The Cereal Drive works to help those struggling with hunger and to promote the importance of eating a healthy breakfast, especially for children who lose access to school-based nutrition programs during the summer months. The 2021 Cereal Drive took place from June 7 to June 14 across Tenet's acute care hospitals, ambulatory facilities, call centers and cor

Tenet Healthcare Announces Results of the 2021 Healthy Over Hungry® Cereal Drive

Tenet Healthcare's (THC) CEO Ron Rittenmeyer on Q2 2021 Results - Earnings Call Transcript

Tenet Healthcare's (THC) second-quarter results gain on the back of higher revenues, and well-performing Hospital, Ambulatory and Conifer segments, partly offset by escalating costs.

News for Tenet Healthcare Stock (THC)